Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Syndicate
Avita Medical files $200M mixed securities shelf  16:48
10/09/20
10/09
16:48
10/09/20
16:48
RCEL

Avita Medical

$26.70 /

+0.5 (+1.91%)

 
ShowHide Related Items >><<
RCEL Avita Medical
$26.70 /

+0.5 (+1.91%)

RCEL Avita Medical
$26.70 /

+0.5 (+1.91%)

08/27/20
Fly Intel: Top five analyst initiations
08/27/20 BofA
Avita Medical assumed with a Buy at BofA
07/09/20 BTIG
Avita Medical price target raised to $41 from $8 at BTIG
07/06/20 Oppenheimer
Avita Medical price target raised to $45 from $9 at Oppenheimer
Conference/Events
Avita Medical management to meet virtually with BTIG » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
RCEL

Avita Medical

$28.77 /

+0.02 (+0.07%)

Virtual Meeting to be…

Virtual Meeting to be held on September 21 hosted by BTIG.

ShowHide Related Items >><<
RCEL Avita Medical
$28.77 /

+0.02 (+0.07%)

RCEL Avita Medical
$28.77 /

+0.02 (+0.07%)

08/27/20
Fly Intel: Top five analyst initiations
08/27/20 BofA
Avita Medical assumed with a Buy at BofA
07/09/20 BTIG
Avita Medical price target raised to $41 from $8 at BTIG
07/06/20 Oppenheimer
Avita Medical price target raised to $45 from $9 at Oppenheimer
Over a month ago
Conference/Events
Avita Medical management to meet virtually with BTIG » 11:55
09/17/20
09/17
11:55
09/17/20
11:55
RCEL

Avita Medical

$28.50 /

+0.26 (+0.92%)

Virtual Meeting to be…

Virtual Meeting to be held on September 21 hosted by BTIG.

ShowHide Related Items >><<
RCEL Avita Medical
$28.50 /

+0.26 (+0.92%)

RCEL Avita Medical
$28.50 /

+0.26 (+0.92%)

08/27/20
Fly Intel: Top five analyst initiations
08/27/20 BofA
Avita Medical assumed with a Buy at BofA
07/09/20 BTIG
Avita Medical price target raised to $41 from $8 at BTIG
07/06/20 Oppenheimer
Avita Medical price target raised to $45 from $9 at Oppenheimer
Hot Stocks
AVITA Therapeutics enrolls first patient in RECELL System pivotal study » 08:24
09/14/20
09/14
08:24
09/14/20
08:24
RCEL

Avita Medical

$26.26 /

+0.26 (+1.00%)

AVITA said in a release,…

AVITA said in a release, "AVITA Therapeutics announced the initiation of the pivotal study assessing the use of the RECELL(R) System to treat stable vitiligo with the enrollment of the first patient at Miami Dermatology and Laser Institute in Miami, FL. The study will evaluate the safety and effectiveness of AVITA Therapeutic's RECELL System to repigment skin in patients who have vitiligo that has been stable for at least one year."

ShowHide Related Items >><<
RCEL Avita Medical
$26.26 /

+0.26 (+1.00%)

RCEL Avita Medical
$26.26 /

+0.26 (+1.00%)

08/27/20
Fly Intel: Top five analyst initiations
08/27/20 BofA
Avita Medical assumed with a Buy at BofA
07/09/20 BTIG
Avita Medical price target raised to $41 from $8 at BTIG
07/06/20 Oppenheimer
Avita Medical price target raised to $45 from $9 at Oppenheimer
Initiation
Fly Intel: Top five analyst initiations » 10:02
08/27/20
08/27
10:02
08/27/20
10:02
GRWG

GrowGeneration

$15.76 /

+1.66 (+11.77%)

, ARCB

ArcBest

$33.88 /

+0.57 (+1.71%)

, SAIA

Saia

$133.97 /

-0.47 (-0.35%)

, RCEL

Avita Medical

$23.49 /

+0.52 (+2.26%)

, MRVL

Marvell

$35.57 /

-0.03 (-0.08%)

, HZNP

Horizon Therapeutics

$73.47 /

+0.45 (+0.62%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. GrowGeneration (GRWG) initiated with a Buy at Stifel. 2. ArcBest (ARCB) was initiated with a Buy at Goldman Sachs while Saia (SAIA) was initiated with a Neutral. 3. Avita Medical (RCEL) assumed with a Buy at BofA. 4. Marvell (MRVL) initiated with an Outperform at Credit Suisse. 5. Horizon Therapeutics (HZNP) initiated with a Buy at Citi. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SAIA Saia
$133.97 /

-0.47 (-0.35%)

RCEL Avita Medical
$23.49 /

+0.52 (+2.26%)

MRVL Marvell
$35.57 /

-0.03 (-0.08%)

HZNP Horizon Therapeutics
$73.47 /

+0.45 (+0.62%)

GRWG GrowGeneration
$15.76 /

+1.66 (+11.77%)

ARCB ArcBest
$33.88 /

+0.57 (+1.71%)

GRWG GrowGeneration
$15.76 /

+1.66 (+11.77%)

08/26/20 Stifel
GrowGeneration initiated with a Buy at Stifel
08/13/20 Alliance Global Partners
GrowGeneration price target raised to $17 from $10 at Alliance Global Partners
07/17/20 Lake Street
GrowGeneration price target raised to $9 from $7 at Lake Street
07/14/20 Oppenheimer
Oppenheimer bullish on GrowGeneration, initiates with an Outperform
ARCB ArcBest
$33.88 /

+0.57 (+1.71%)

08/27/20 Goldman Sachs
ArcBest initiated with a Buy at Goldman Sachs
07/17/20 Truist
SunTrust raises price targets in select Trucking/Logistics names
07/07/20 Wolfe Research
ArcBest upgraded to Outperform from Peer Perform at Wolfe Research
06/03/20 BofA
BofA double upgrades ArcBest to Buy on improving prospects
SAIA Saia
$133.97 /

-0.47 (-0.35%)

08/27/20 Goldman Sachs
Saia initiated with a Neutral at Goldman Sachs
07/30/20 Deutsche Bank
Saia price target raised to $145 from $133 at Deutsche Bank
07/28/20
Fly Intel: Top five analyst initiations
07/28/20 BofA
Saia initiated with a Neutral at BofA
RCEL Avita Medical
$23.49 /

+0.52 (+2.26%)

08/27/20 BofA
Avita Medical assumed with a Buy at BofA
07/09/20 BTIG
Avita Medical price target raised to $41 from $8 at BTIG
07/06/20 Oppenheimer
Avita Medical price target raised to $45 from $9 at Oppenheimer
04/20/20 Oppenheimer
Avita Medical initiated with an Outperform at Oppenheimer
MRVL Marvell
$35.57 /

-0.03 (-0.08%)

08/27/20 Credit Suisse
Marvell initiated with an Outperform at Credit Suisse
08/24/20 Benchmark
Marvell price target raised to $40 from $35 at Benchmark
08/21/20 Oppenheimer
Marvell price target raised to $40 from $35 at Oppenheimer
08/21/20 Oppenheimer
Marvell price target raised to $40 from $35 at Oppenheimer
HZNP Horizon Therapeutics
$73.47 /

+0.45 (+0.62%)

08/27/20 Piper Sandler
Piper survey points to longer-term growth for Horizon's Krystexxa
08/27/20 Citi
Horizon Therapeutics initiated with a Buy at Citi
08/06/20 Guggenheim
Horizon Therapeutics price target raised to $100 from $64 at Guggenheim
07/31/20 Stifel
Horizon Therapeutics price target raised to $85 from $60 at Stifel
SAIA Saia
$133.97 /

-0.47 (-0.35%)

MRVL Marvell
$35.57 /

-0.03 (-0.08%)

HZNP Horizon Therapeutics
$73.47 /

+0.45 (+0.62%)

GRWG GrowGeneration
$15.76 /

+1.66 (+11.77%)

ARCB ArcBest
$33.88 /

+0.57 (+1.71%)

  • 07
    Aug
  • 30
    Jun
MRVL Marvell
$35.57 /

-0.03 (-0.08%)

GRWG GrowGeneration
$15.76 /

+1.66 (+11.77%)

MRVL Marvell
$35.57 /

-0.03 (-0.08%)

HZNP Horizon Therapeutics
$73.47 /

+0.45 (+0.62%)

GRWG GrowGeneration
$15.76 /

+1.66 (+11.77%)

RCEL Avita Medical
$23.49 /

+0.52 (+2.26%)

MRVL Marvell
$35.57 /

-0.03 (-0.08%)

GRWG GrowGeneration
$15.76 /

+1.66 (+11.77%)

Initiation
Avita Medical assumed with a Buy at BofA » 06:16
08/27/20
08/27
06:16
08/27/20
06:16
RCEL

Avita Medical

$22.97 /

+2.07 (+9.90%)

BofA analyst Lyanne…

BofA analyst Lyanne Harrison assumed coverage of Avita Medical with a Buy rating and $42 price target.

ShowHide Related Items >><<
RCEL Avita Medical
$22.97 /

+2.07 (+9.90%)

RCEL Avita Medical
$22.97 /

+2.07 (+9.90%)

07/09/20 BTIG
Avita Medical price target raised to $41 from $8 at BTIG
07/06/20 Oppenheimer
Avita Medical price target raised to $45 from $9 at Oppenheimer
04/20/20 Oppenheimer
Avita Medical initiated with an Outperform at Oppenheimer
03/05/20 Lake Street
Avita Medical pullback brings buying opportunity, says Lake Street
RCEL Avita Medical
$22.97 /

+2.07 (+9.90%)

Over a quarter ago
Hot Stocks
Avita Medical announces BARDA to procure Recell System in VMI plan for $7.6M » 08:04
07/13/20
07/13
08:04
07/13/20
08:04
RCEL

Avita Medical

$27.23 /

-1.82 (-6.27%)

Avita Therapeutics…

Avita Therapeutics announced that the Biomedical Advanced Research and Development Authority, or BARDA, a part of the Office of the Assistant Secretary for Preparedness and Response, or ASPR, at the U.S. Department of Health and Human Services, or HHS, will procure the Recell System as part of the HHS mission to build preparedness for public health emergencies. BARDA has agreed to the purchase, storage and delivery of Recell Systems utilizing a vendor-managed inventory, or VMI, plan valued at $7.6M. Further, BARDA has expanded its awarded contract to provide supplemental funding of $1.6M to support emergency deployment of Recell Systems for use in mass casualty or other emergency situations. Delivery of Recell Systems under the VMI plan is expected to commence later this calendar year.

ShowHide Related Items >><<
RCEL Avita Medical
$27.23 /

-1.82 (-6.27%)

RCEL Avita Medical
$27.23 /

-1.82 (-6.27%)

07/09/20 BTIG
Avita Medical price target raised to $41 from $8 at BTIG
07/06/20 Oppenheimer
Avita Medical price target raised to $45 from $9 at Oppenheimer
04/20/20 Oppenheimer
Avita Medical initiated with an Outperform at Oppenheimer
03/05/20 Lake Street
Avita Medical pullback brings buying opportunity, says Lake Street
RCEL Avita Medical
$27.23 /

-1.82 (-6.27%)

Recommendations
Avita Medical price target raised to $41 from $8 at BTIG » 06:48
07/09/20
07/09
06:48
07/09/20
06:48
RCEL

Avita Medical

$29.76 /

-0.05 (-0.17%)

BTIG analyst Ryan…

BTIG analyst Ryan Zimmerman raised the firm's price target on Avita Medical to $41 from $8 and keeps a Buy rating on the shares. The analyst notes that his investor call with a UMass Medical School associate professor in the Dermatology department suggests that his prior estimate of addressable vitiligo patient market could prove to be "conservative", also stating that RECELL opportunity may be materially higher. Zimmerman adds that his higher price target on Avita also reflects the impact of Avita's recent redomiciliation on its share count.

ShowHide Related Items >><<
RCEL Avita Medical
$29.76 /

-0.05 (-0.17%)

RCEL Avita Medical
$29.76 /

-0.05 (-0.17%)

07/06/20 Oppenheimer
Avita Medical price target raised to $45 from $9 at Oppenheimer
04/20/20 Oppenheimer
Avita Medical initiated with an Outperform at Oppenheimer
03/05/20 Lake Street
Avita Medical pullback brings buying opportunity, says Lake Street
03/03/20 BTIG
Avita Medical initiated with a Buy at BTIG
RCEL Avita Medical
$29.76 /

-0.05 (-0.17%)

Recommendations
Avita Medical price target raised to $45 from $9 at Oppenheimer » 08:22
07/06/20
07/06
08:22
07/06/20
08:22
RCEL

Avita Medical

$29.90 /

+0.48 (+1.63%)

Oppenheimer analyst Kevin…

Oppenheimer analyst Kevin DeGeeter raised the firm's price target on Avita Medical to $45 from $9 following successful redomicile to the U.S. and a concurrent 1:5 reverse stock split. The analyst keeps an Outperform rating on the shares.

ShowHide Related Items >><<
RCEL Avita Medical
$29.90 /

+0.48 (+1.63%)

RCEL Avita Medical
$29.90 /

+0.48 (+1.63%)

04/20/20 Oppenheimer
Avita Medical initiated with an Outperform at Oppenheimer
03/05/20 Lake Street
Avita Medical pullback brings buying opportunity, says Lake Street
03/03/20 BTIG
Avita Medical initiated with a Buy at BTIG
12/31/19 Lake Street
Avita Medical's new CFO a 'perfect fit,' says Lake Street
RCEL Avita Medical
$29.90 /

+0.48 (+1.63%)

Hot Stocks
AVITA Medical implements scheme to redomicile to U.S. from Australia » 05:42
06/29/20
06/29
05:42
06/29/20
05:42
RCEL

Avita Medical

$5.21 /

-0.445 (-7.88%)

AVITA Medical announced…

AVITA Medical announced that the scheme of arrangement to effect the redomiciliation of the Company and its subsidiaries from Australia to the United States of America has been implemented. AVITA said in a release, "As previously announced, the Scheme was approved by the Company's shareholders at the Scheme meeting held via live webcast on 15 June 2020 and approved by the Federal Court of Australia on June 22. In accordance with the Scheme, all ordinary shares in the Company have today been transferred to AVITA Therapeutics, Inc. (Avita US), a company incorporated in the State of Delaware in the United States of America. Avita US is now the sole shareholder in the Company and the ultimate parent company of the Avita Group."

ShowHide Related Items >><<
RCEL Avita Medical
$5.21 /

-0.445 (-7.88%)

RCEL Avita Medical
$5.21 /

-0.445 (-7.88%)

04/20/20 Oppenheimer
Avita Medical initiated with an Outperform at Oppenheimer
03/05/20 Lake Street
Avita Medical pullback brings buying opportunity, says Lake Street
03/03/20 BTIG
Avita Medical initiated with a Buy at BTIG
12/31/19 Lake Street
Avita Medical's new CFO a 'perfect fit,' says Lake Street
RCEL Avita Medical
$5.21 /

-0.445 (-7.88%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.